UnitedHealth Group Incorporated $UNH Shares Sold by Penobscot Investment Management Company Inc.

Key Points

• Penobscot Investment Management Company Inc. reduced its stake in UnitedHealth Group by 33.9% during Q2, holding 17,923 shares worth approximately $5.59 million after selling 9,180 shares.
• Majority of analysts maintain a Hold rating for UnitedHealth Group, with a consensus price target of $358.95, although price targets from various firms have ranged from $267.00 to $418.00.
• UnitedHealth Group's recent earnings report showed a year-over-year revenue increase of 12.9%, with earnings per share of $4.08, which didn't meet analysts' expectations of $4.45.

Penobscot Investment Management Company Inc. lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 33.9% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 17,923 shares of the healthcare conglomerate's stock after selling 9,180 shares during the quarter. Penobscot Investment Management Company Inc.'s holdings in UnitedHealth Group were worth $5,591,000 as of its most recent filing with the SEC.

Several other large investors also recently bought and sold shares of UNH. Bayforest Capital Ltd grew its holdings in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd grew its stake in shares of UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after acquiring an additional 50 shares in the last quarter. IAG Wealth Partners LLC acquired a new position in shares of UnitedHealth Group in the first quarter worth about $42,000. Kentucky Trust Co grew its stake in UnitedHealth Group by 53.8% during the 2nd quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate's stock valued at $45,000 after purchasing an additional 50 shares in the last quarter. Finally, O Brien Wealth Partners LLC raised its position in shares of UnitedHealth Group by 74.0% in the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock valued at $46,000 after purchasing an additional 37 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Analysts Set New Price Targets

Several research firms recently issued reports on UNH. Wells Fargo & Company cut their price target on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Bank of America increased their price target on shares of UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a research report on Monday, August 18th. JPMorgan Chase & Co. lowered their price objective on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a report on Wednesday, August 6th. Sanford C. Bernstein lifted their target price on UnitedHealth Group from $337.00 to $379.00 and gave the stock an "outperform" rating in a research report on Friday, September 5th. Finally, KeyCorp reduced their price objective on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $358.95.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $360.17 on Friday. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The firm has a market capitalization of $326.20 billion, a PE ratio of 15.61, a P/E/G ratio of 2.30 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The business's fifty day moving average price is $307.84 and its two-hundred day moving average price is $355.58.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm's revenue was up 12.9% on a year-over-year basis. During the same period last year, the business earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.